What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study).

Exploring the Anti‐inflammatory Molecular Mechanism of L‐shikonin in Promoting Diabetic Wound Healing by Modulating the Janus Kinase/Phosphatidylinositol‐3‐kinase/Protein Kinase B/Vascular Endothelial Growth Factor Pathway Based on Network Pharmacology

View Full Paper

Ask AI

Bookmark

Authors

Investigation reveals l-shikonin promotes wound healing in diabetic foot ulcers by modulating macrophage polarization and the jaks/PI3K/AKT pathway.

L-shikonin treatment significantly enhanced wound closure in diabetic foot ulcers, indicating its therapeutic promise.
The pathway interactions of jaks and PI3K were crucial for modulating inflammatory responses and promoting healing.
This study utilized a diabetic murine model and in vitro human macrophage assays to validate its findings on L-shikonin's effects.
Results highlight the necessary dual action of L-shikonin on macrophage phenotype reprogramming and angiogenic pathway activation.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Investigation reveals l-shikonin promotes wound healing in diabetic foot ulcers by modulating macrophage polarization and the jaks/PI3K/AKT pathway.

L-shikonin treatment significantly enhanced wound closure in diabetic foot ulcers, indicating its therapeutic promise.
The pathway interactions of jaks and PI3K were crucial for modulating inflammatory responses and promoting healing.
This study utilized a diabetic murine model and in vitro human macrophage assays to validate its findings on L-shikonin's effects.
Results highlight the necessary dual action of L-shikonin on macrophage phenotype reprogramming and angiogenic pathway activation.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark